Revelation Pharma Acquires Cascade Specialty Pharmacy

Revelation Pharma (Osceola Capital) Acquires Five Compounding Pharmacies

January 27, 2022

Healthcare Services

Revelation Pharma, a PE-backed specialty pharmacy platform sponsored by Osceola Capital, completed add-on acquisitions of five compounding pharmacies: Innovation Compounding, Pencol Compounding Pharmacy, Pharmacy Specialists Compounding, Wise Pharmacy, and Convex Pharmacy. The deals expand Revelation's geographic footprint and clinical capabilities across key U.S. regions and will see some locations merged into existing Revelation businesses (e.g., Wise into Pencol; Convex into Everwell).

Revelation Pharma Acquires Taylors Pharmacy and Key Compounding Pharmacy

July 9, 2024

Healthcare Services

Revelation Pharma, a national network of 503A and 503B compounding pharmacies, has acquired Taylors Pharmacy (Florida) and Key Compounding Pharmacy (Federal Way, Washington). The acquisitions expand Revelation's coast-to-coast footprint and bring both pharmacies into its compounding network as Revelation assumes full operations; the sellers are the founders/owners Allen Deaver and HeeJoo Park.

Revelation Pharma Acquires Acacia Apothecary & Wellness

October 9, 2025

Healthcare Services

Revelation Pharma, a national network of 503A and 503B compounding pharmacies, has acquired Acacia Apothecary & Wellness, a Tucson-based compounding pharmacy. The deal expands Revelation's footprint and expertise in hormone therapy, women's health, and personalized medicine; Acacia founder Justin Brock, PharmD, will join Revelation as an Operational Consultant.

Osceola Capital-Backed Revelation Pharma Acquires Everwell Specialty Pharmacy

March 23, 2021

Healthcare Services

Osceola Capital formed Revelation Pharma Corp as a pharmacy compounding platform in partnership with industry veteran Jacob Beckel and concurrently completed the acquisition of Pensacola-based Everwell Specialty Pharmacy. Revelation will pursue consolidation of 503A compounding pharmacies nationally, with Everwell serving as the initial platform asset focused on anti-infectives, specialty compounding and other therapeutic classes.

Revelation Pharma (Osceola Capital) Acquires Harrow Health's Non‑Ophthalmic Compounding Business

October 12, 2022

Healthcare Services

Osceola Capital-backed Revelation Pharma has acquired the non-ophthalmic compounding business of NASDAQ-listed Harrow Health as the twelfth add-on to the Revelation platform. The deal lets Revelation expand its national footprint of 503A and 503B compounding pharmacies while Harrow focuses solely on ophthalmic medications.

Revelation Pharma Acquires Wedgewood Pharmacy's Human-Health Book of Business

June 16, 2022

Healthcare Services

Osceola Capital's Revelation Pharma platform acquired the human-health book of business from Wedgewood Pharmacy, marking the eighth add-on for the Revelation platform. The deal allows Wedgewood to focus exclusively on veterinary compounding while expanding Revelation's national network of 503A/503B compounding pharmacies; terms were not disclosed.